Related Experiment Video
Updated: Apr 29, 2026

Differentiation of Mouse Breast Epithelial HC11 and EpH4 Cells
Published on: February 27, 2020
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells
Vikram B Wali1, Jonathan W Haskins2, Maureen Gilmore-Hebert2
1Department of Pathology, Yale School of Medicine, New Haven, Connecticut vikram.wali@yale.edu.
Unlabelled:
Associations of ErbB4 (ERBB4/HER4), the fourth member of the EGFR family, with cancer are variable, possibly as a result of structural diversity of this receptor. There are multiple structural isoforms of ERBB4 arising by alternative mRNA splicing, and a subset undergo proteolysis that releases membrane-anchored and soluble isoforms that associate with transcription factors and coregulators to modulate transcription. To compare the differential and common signaling activities of full-length (FL) and soluble intracellular isoforms of ERBB4, four JM-a isoforms (FL and soluble intracellular domain (ICD) CYT-1 and CYT-2) were expressed in isogenic MCF10A cells and their biologic activities were analyzed. Both FL and ICD CYT-2 promoted cell proliferation and invasion, and CYT-1 suppressed cell growth. Transcriptional profiling revealed several new and underexplored ERBB4-regulated transcripts, including: proteases/protease inhibitors (MMP3 and SERPINE2), the YAP/Hippo pathway (CTGF, CYR61, and SPARC), the mevalonate/cholesterol pathway (HMGCR, HMGCS1, LDLR, and DHCR7), and cytokines (IL8, CCL20, and CXCL1). Many of these transcripts were subsequently validated in a luminal breast cancer cell line that normally expresses ERBB4. Furthermore, ChIP-seq experiments identified ADAP1, APOE, SPARC, STMN1, and MXD1 as novel molecular targets of ERBB4. These findings clarify the diverse biologic activities of ERBB4 isoforms, and reveal new and divergent functions.
Implications:
ErbB4 as a regulator of Hippo and mevalonate pathways provides new insight into milk production and anabolic processes in normal mammary epithelia and cancer.
Insights
ErbB4 (ERBB4/HER4) receptor isoforms have diverse roles in cell growth and cancer. This study identified new targets and pathways regulated by ErbB4, including the Hippo and mevalonate pathways, offering insights into mammary biology and cancer.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- ErbB4 (ERBB4/HER4) is a member of the EGFR family with variable associations with cancer, potentially due to its structural diversity.
- Alternative mRNA splicing and proteolysis generate multiple ErbB4 isoforms, including membrane-anchored and soluble forms that regulate transcription.
Purpose of the Study:
- To compare the signaling activities of full-length (FL) and soluble intracellular isoforms of ErbB4.
- To identify novel ErbB4-regulated transcripts and molecular targets.
Main Methods:
- Expression of four JM-a ErbB4 isoforms (FL, ICD CYT-1, ICD CYT-2) in isogenic MCF10A cells.
- Analysis of biologic activities, including cell proliferation and invasion.
- Transcriptional profiling and ChIP-seq experiments.
- Validation in a luminal breast cancer cell line.
Main Results:
- FL and ICD CYT-2 promoted cell proliferation and invasion; ICD CYT-1 suppressed cell growth.
- Identified new ErbB4-regulated transcripts in proteases, YAP/Hippo pathway, mevalonate/cholesterol pathway, and cytokines.
- Validated several transcripts in breast cancer cells.
- ChIP-seq identified ADAP1, APOE, SPARC, STMN1, and MXD1 as novel ErbB4 molecular targets.
Conclusions:
- ErbB4 isoforms exhibit diverse biological activities.
- ErbB4 regulates the Hippo and mevalonate pathways, providing new insights into mammary epithelial processes and cancer.
Related Concept Videos
Mitogens and the Cell Cycle
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Diversity in Cell Signaling Responses
Graded and Abrupt Responses
Some signaling systems generate...

